Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00950677 · ClinicalTrials.gov registry record · Phase 4
The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes
A Phase 4 study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT00950677 is a Phase 4 study that has completed, run by Baylor College of Medicine. The registered enrollment target is 16 participants.
The verdict
NCT00950677, a Phase 4 study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to see if giving study drugs before a meal may lower blood sugars after the meal. An improvement in blood sugar control may prevent long-term problems of diabetes.
Interventions
- DRUG Byetta (exenatide)
- DRUG Symlin (pramlintide)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00950677
The ClinicalTrials.gov registry entry for NCT00950677 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Byetta (exenatide) is the first listed.
NCT00950677 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00950677 about?
NCT00950677 is a clinical study titled "The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes". The purpose of this study is to see if giving study drugs before a meal may lower blood sugars after the meal. An improvement in blood sugar control may prevent long-term problems of diabetes.
What is the current status of trial NCT00950677?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2009-07. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00950677?
The interventions under investigation include: Byetta (exenatide) (DRUG), Symlin (pramlintide) (DRUG).
Who is sponsoring clinical trial NCT00950677?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.